PainReform Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
1.470
-0.020 (-1.34%)
At close: Jul 24, 2025, 4:00 PM
1.460
-0.010 (-0.68%)
After-hours: Jul 24, 2025, 4:12 PM EDT
PainReform Market Cap
PainReform has a market cap or net worth of $2.96 million as of July 24, 2025. Its market cap has increased by 149.96% in one year.
Market Cap
2.96M
Enterprise Value
-1.26M
1-Year Change
149.96%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since the IPO on September 1, 2020, PainReform's market cap has decreased from $69.97M to $2.96M, a decrease of -95.77%. That is a compound annual growth rate of -47.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2025 | 3.00M | 2.19% |
| Dec 31, 2024 | 2.94M | -31.51% |
| Dec 29, 2023 | 4.29M | -2.35% |
| Dec 30, 2022 | 4.39M | -68.52% |
| Dec 31, 2021 | 13.94M | -65.00% |
| Dec 31, 2020 | 39.83M | -43.08% |
| Sep 1, 2020 | 69.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.24B |
| Johnson & Johnson | 395.46B |
| AbbVie | 326.52B |
| Novo Nordisk | 286.26B |
| UnitedHealth Group | 255.94B |
| Novartis AG | 222.44B |
| Abbott Laboratories | 216.47B |
| AstraZeneca | 214.29B |